HCG Manavata Oncology LLP - healthcare in Bangalore, Karnataka, India. FY 2026 financials & compliance.
LLPIN AAH-1208 Incorporated 10 August 2016 ROC Bangalore HQ Bangalore, Karnataka, India
Active Limited Liability Partnership healthcare
Data last updated
Revenue · FY 2022
₹100.36 Cr
Latest filing
Net loss · FY 2022
₹5.9 Cr
Net margin -5.9%
EBITDA · FY 2022
₹12.84 Cr
EBITDA margin 12.8%
Contribution obligation
₹65.7 Cr
As per LLP agreement
Open charges
₹44.26 Cr
Secured borrowings
LLP age
10 yrs
Est. 2016
Employees · EPFO
384
Provident fund records
Designated partners
2
As per MCA filings

About HCG Manavata Oncology LLP

Data last updated:

HCG Manavata Oncology LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 10 August 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAH-1208. Its GSTIN is 27AAJFH7712H1Z9 (Maharashtra).

The LLP has a total obligation of contribution of ₹65.7 Cr. It is led by designated partners Rajnish Vasantrao Nagarkar and Srinivasa Venkatavaradhan Raghavan.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Hcg Tower No. 8 Sampangi Ram Nagar, Bangalore, Karnataka, India – 560018.

As per the financials filed for FY 2022, the LLP reported a revenue of ₹100.36 Cr. For the same year it recorded a net loss of ₹5.9 Cr (net margin -5.9%) and EBITDA of ₹12.84 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 96% over five years.

The LLP has about 384 employees on its provident fund (EPFO) records.

As per MCA filings, the LLP has open charges of ₹44.26 Cr on record. Court records list 1 case involving the LLP, including 1 filed by the LLP; 1 case is pending.

For more details, the LLP can be reached via its website hcgoncology.com.

Company details

LLPIN AAH-1208
Incorporation Date 10 August 2016
Total Obligation of Contribution ₹65.7 Cr
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025

Contact details

HCG Manavata Oncology LLP's registered office is in Bangalore, Karnataka. Its website is hcgoncology.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Hcg Tower No. 8 Sampangi Ram Nagar, Bangalore, Karnataka, India – 560018
  • Industry
    Healthcare, Oncology Clinics & Cancer Treatment

To see the full contact details of HCG Manavata Oncology LLP, buy the company report.

Comprehensive company report
HCG Manavata Oncology LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of HCG Manavata Oncology LLP

FY 2025 filings available

HCG Manavata Oncology LLP reported revenue of ₹100.36 Cr for FY 2022.

Revenue · FY 2022
₹100.36 Cr
Net loss · FY 2022
₹5.9 Cr margin -5.9%
EBITDA · FY 2022
₹12.84 Cr margin 12.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
5 years · compounded
▲ 96%
EBITDA CAGR growth
5 years · compounded
▲ 55%

Revenue has grown at a compounded annual rate (CAGR) of 96% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Income and Expenditure
Turnover
Other Income
Total Income₹100.36 Cr
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax-₹5.9 Cr
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
Net Profit Margin-5.9%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of HCG Manavata Oncology LLP, buy the company report.

Designated partners of HCG Manavata Oncology LLP

HCG Manavata Oncology has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Rajnish Vasantrao NagarkarDesignated Partner10 Aug 201610 Years 2 MonthsCurrent
Srinivasa Venkatavaradhan RaghavanDesignated Partner24 Aug 20197 Years 2 MonthsCurrent

Charges & borrowings

Open charges
₹44.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Yes Bank Limited₹43.93 Cr
Siemens Financial Services Private Limited₹0.33 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Oct 2023100844162Siemens Financial Services Private Limited₹33.38 LakhOpen
05 Sep 2018100221231Yes Bank Limited₹8.25 CrOpen
07 Nov 2017100152331Yes Bank Limited₹35.68 CrOpen

To see the full charge records of HCG Manavata Oncology LLP, buy the company report.

Total charge records: 3 View all charges

Credit ratings & regulatory alerts

HCG Manavata Oncology LLP was last rated by Care on 01 Dec 2022.

Rating agencyRated onRating
Care01 Dec 2022

To see the full credit ratings and regulatory alerts of HCG Manavata Oncology LLP, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for HCG Manavata Oncology LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

HCG Manavata Oncology LLP has a workforce of 384 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
384
Active EPFO establishments
1
Employee growth
-9%

GST

HCG Manavata Oncology has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAJFH7712H1Z9MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of HCG Manavata Oncology LLP, buy the company report.

Recent activity

HCG Manavata Oncology LLP has 3 designated partner changes on record since 2016: 2 appointments and 1 cessation. The latest: Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner on 24 Aug 2019.

AGM
Hcg Manavata Oncology Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Hcg Manavata Oncology Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Charges
A charge with Yes Bank Limited of Rs. 8.25 Cr registered on 05 Sep 2018 with Charge ID 100221231 was modified on 07 Nov 2024.
Charges
A charge with Yes Bank Limited of Rs. 35.68 Cr registered on 07 Nov 2017 with Charge ID 100152331 was modified on 07 Nov 2024.
Charges
A charge with Siemens Financial Services Private Limited amounted to Rs. 0.33 Cr with Charge ID 100844162 was registered on 12 Oct 2023.
Appointed
Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner.
Ceased
Dinesh Madhavan ceased to be Designated Partner.
Charges
A charge with Yes Bank Limited amounted to Rs. 8.25 Cr with Charge ID 100221231 was registered on 05 Sep 2018.
Charges
A charge with Yes Bank Limited amounted to Rs. 35.68 Cr with Charge ID 100152331 was registered on 07 Nov 2017.
Appointed
Rajnish Vasantrao Nagarkar was appointed as Designated Partner.
Incorporation
10 Aug 2016
Hcg Manavata Oncology Llp was registered on 10 Aug 2016 with Roc Bangalore & aged 10 years 2 months as per MCA records.

Frequently asked questions

HCG Manavata Oncology is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 10 August 2016 (10+ years old) and is registered under LLPIN AAH-1208.

HCG Manavata Oncology has 2 current designated partners:

The latest financial statements of HCG Manavata Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of HCG Manavata Oncology is 27AAJFH7712H1Z9, registered in Maharashtra.

The LLPIN (Limited Liability Partnership Identification Number) of HCG Manavata Oncology is AAH-1208. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

HCG Manavata Oncology has 1 court case on record: 1 filed by the LLP. 1 is pending.

HCG Manavata Oncology was incorporated on 10 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.

Srinivasa Venkatavaradhan Raghavan was appointed as Designated Partner on 24 Aug 2019. Dinesh Madhavan ceased to be Designated Partner on 23 Aug 2019. Rajnish Vasantrao Nagarkar was appointed as Designated Partner on 10 Aug 2016.

HCG Manavata Oncology can be reached through the website hcgoncology.com. Its registered office is in Bangalore, Karnataka, India.

The registered office of HCG Manavata Oncology is at Hcg Tower No. 8 Sampangi Ram Nagar, Bangalore, Karnataka, India – 560018.